机构地区:[1]西安交通大学第二附属医院肿瘤科,710004 [2]西安交通大学第二附属医院中医科,710004 [3]西安交通大学第二附属医院心理科,710004
出 处:《中国实用护理杂志》2019年第29期2280-2284,共5页Chinese Journal of Practical Nursing
摘 要:目的探讨揿针皮内埋针治疗乳腺癌患者心脾两虚型失眠的临床方法和治疗效果。方法选择2018年3-11月肿瘤科收住院的乳腺癌心脾两虚型失眠患者80例,按照随机数字表法为试验组和对照组,每组40例。试验组使用揿针皮内埋针治疗,以神门、三阴交、安眠、足三里为主穴,太白为配穴,对照组在相同穴位贴假针,共治疗4周,采用匹兹堡睡眠质量指数量表(PSQI)进行疗效评估,并观察不良反应。结果2组患者治疗前PSQI各维度评分和总分比较差异无统计学意义(P>0.05)。试验组治疗后睡眠质量、入睡时间、睡眠时间、睡眠效率、睡眠障碍、日间功能障碍及总分分别为(1.58±0.53)、(1.72±0.33)、(1.57±0.64)、(1.61±0.68)、(1.05±0.42)、(1.27±0.53)、(8.91±2.73)分,对照组分别为(1.86±0.71)、(1.90±0.41)、(1.85±0.47)、(1.97±0.83)、(1.42±0.91)、(1.56±0.45)、(10.86±4.53)分,2组比较差异有统计学意义(t=1.998~2.637,P<0.05)。试验组临床治愈8例,显效13例,有效9例,无效10例,对照组分别为1、5、12、22例,2组患者临床疗效比较差异有统计学意义(χ^2=27.68,P<0.01)。未发生感染、针体脱落等不良反应。结论揿针皮内埋针可以提高乳腺癌心脾两虚型失眠患者的睡眠质量,且操作简便、安全、不良反应小。Objective To explore the clinical therapeutic method and effect of the thumb-tack needle for subcutaneous embedding therapy on treating insomnia with insufficiency of heart and spleen among breast cancer patients. Methods Totally 80 breast cancer patients with insomnia with insufficiency of heart and spleen treated in department of oncology, the Second Affiliated Hospital of Xi′an Jiao Tong University from March 2018 till November 2018 were selected and assigned into an experiment group and a control group by random number table, 40 cases in each one. The experiment group applied thumb-tack needle for subcutaneous embedding therapy, selecting Shenmen, Sanyinjiao, Zusanli, Anmian as major acupoint and Taibai as assistant acupoint. The control group used fake needles at the same places. After four-week treatment, we evaluated the therapeutic effect using the Pittsburgh Sleep Quality Index (PSQI) and observed side effects. Results Before treatment, no significantly statistical differences were observed between the two groups on global and each dimension′s PSQI scores (P>0.05). After treatment, the PSQI scores and PSQI global score of the experiment group on sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, and daytime dysfunction were (1.58±0.53),(1.72±0.33),(1.57±0.64),(1.61±0.68),(1.05±0.42),(1.27±0.53),(8.91±2.73) points respectively, which were (1.86±0.71),(1.90±0.41),(1.85±0.47),(1.97±0.83),(1.42±0.91),(1.56±0.45),(10.86±4.53) points respectively in the control group. There was significant difference between the two groups on PSQI global scores (t=1.998-2.637, P<0.05). The number of patients in the experiment group assessed as clinical cure, obviously effective, effective and noneffective were 8, 13, 9, 10 respectively, which were 1, 5, 12, 22 in the control group respectively. The clinical efficacy showed significant difference between the two groups (χ^2=27.68, P<0.01). No side effects, such as infection, needle drop-off and etc. were observed. Conclusions
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...